<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
HZNP
Horizon Therapeutics
$
()


  • Paulson exits Newmont, boosts Madrigal in Q3

    11/14/2023 - 20:53pm
  • Soros Fund buys Splunk, exits Rivian in Q3

    11/14/2023 - 16:55pm
  • Amgen price target raised to $336 from $293 at TD Cowen

    10/25/2023 - 07:32am
  • Four new option listings and nineteen option delistings on October 24th

    10/24/2023 - 08:30am
  • Amgen price target raised to $320 from $265 at Wells Fargo

    10/12/2023 - 06:26am
  • Amgen upgraded to Outperform from Market Perform at Leerink

    10/11/2023 - 06:35am
  • Amgen completes acquisition of Horizon Therapeutics

    10/6/2023 - 08:32am
  • Horizon Pharma put volume heavy and directionally bearish

    10/5/2023 - 10:35am
  • Horizon Therapeutics announces acquisition by Amgen approved in Ireland

    10/5/2023 - 07:45am
  • Larimar Therapeutics appoints Horizon Therapeutics CMO Jeffrey Sherman to board

    10/3/2023 - 16:16pm
  • Horizon Therapeutics announces new data on TEPEZZA treatment

    9/29/2023 - 10:07am
  • Q32, Horizon announce dosing of first patient in Phase 2 Bempikibart trial

    9/13/2023 - 10:45am
  • Horizon Therapeutics downgraded to Hold from Buy at Jefferies

    9/1/2023 - 13:33pm
  • What You Missed On Wall Street This Morning

    9/1/2023 - 12:18pm
  • Amgen, Horizon enter consent order agreement with FTC to close acquisition

    9/1/2023 - 09:25am
dynamic_feed Breaking News